Treatment of HCV/HIV coinfection with leukocyte derived interferon alfa-n3.

被引：0
|
作者：
Sherman, KE
Lalezari, J
Brand, JD
Yoffe, B
Yangco, B
Fedorczyk, D
机构：
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[2] Quest Clin Res, San Francisco, CA USA
[3] Oaklawn Physicians, Dallas, TX USA
[4] Baylor Coll Med, Houston, TX 77030 USA
[5] Infect Dis Res Inst, Tampa, FL USA
[6] Interferon Sci, New Brunswick, NJ USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)81854-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
6733
引用
收藏
页码：A1487 / A1487
页数：1
相关论文
共 50 条
  • [21] Ribavirin and interferon treatment in HCV-HIV coinfection: Same efficacy but more side effects than in HIV negative patients.
    Aumaitre, H
    Schiemann, R
    Branger, M
    Ralaimazava, P
    Baut, E
    Coulaud, JP
    Bouchaud, O
    HEPATOLOGY, 2001, 34 (04) : 589A - 589A
  • [22] Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection
    Henry, David H.
    Slim, Jihad
    Lamarca, Anthony
    Bowers, Peter
    Leitz, Gerhard
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (01) : 1 - 9
  • [23] STARTVerso 4 Phase III trial of faldaprevir plus peg interferon alfa-2a and ribavirin (PR) in patients with HIV and HCV genotype 1 coinfection: end of treatment response
    Rockstroh, Juergen K.
    Nelson, Mark
    Soriano, Vincent
    Arasteh, Keikawus
    Maria Guardiola, Jose
    Bhagani, Sanjay
    Mallolas, Josep
    Tural, Christina
    Puoti, Massimo
    Ingiliz, Patrick
    Battegay, Manuel
    Jain, Mamta K.
    Nunez, Marina
    Marks, Kristen M.
    Kort, Jens J.
    Stern, Jerry O.
    Vinisko, Richard
    Manero, Montserrat
    Dieterich, Douglas T.
    HEPATOLOGY, 2013, 58 : 741A - 742A
  • [24] Response to interferon treatment in patients with chronic hepatitis and HCV/HGV coinfection.
    Benetti, GP
    Ramella, G
    Lazza, M
    Corbellini, A
    Vitaliani, G
    Fasola, M
    Portera, G
    Ribero, ML
    Tagger, A
    HEPATOLOGY, 1997, 26 (04) : 1410 - 1410
  • [25] Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
    Hart, Janine
    Ott, Claudia
    Kirchner, Gabriele
    Salzberger, Bernd
    Wiest, Reiner
    CLINICS AND PRACTICE, 2012, 2 (03) : 157 - 160
  • [26] Natural history and treatment of HCV/HIV coinfection: Is it time to change paradigms?
    Arends, Joop E.
    Lieveld, Faydra I.
    Boeijen, Lauke L.
    de Kanter, Clara T. M. M.
    van Erpecum, Karel J.
    Salmon, Dominique
    Hoepelman, Andy I. M.
    Asselah, Tarik
    Ustianowski, Andrew
    JOURNAL OF HEPATOLOGY, 2015, 63 (05) : 1254 - 1262
  • [27] HIV/HCV coinfection: modern treatment strategies, problems in Eastern Europe
    Mazus, Alexey
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 : 37 - 37
  • [28] The Impact of HIV Coinfection on Hepatitis C Virus (HCV) Treatment Initiation
    Henegar, Cassidy E.
    Beckerman, Robin
    Fusco, Jennifer
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 494 - 495
  • [29] HCV quasispecies evolution during treatment with interferon alfa-2b and ribavirin in two children coinfected with HCV and HIV-1
    Quesnel-Vallieres, Mathieu
    Lemay, Mireille
    Lapointe, Normand
    Martin, Steven R.
    Soudeyns, Hugo
    JOURNAL OF CLINICAL VIROLOGY, 2008, 43 (02) : 236 - 240
  • [30] Effectiveness of Hepatitis C Virus (HCV) Antiviral Treatment in Veterans With HIV-HCV Coinfection
    Kramer, Jennifer R.
    Kanwal, Fasiha
    Mei, Minghua
    Giordano, Thomas P.
    El-Serag, Hashem
    GASTROENTEROLOGY, 2011, 140 (05) : S895 - S895
12345